Qilong capsule prevents myocardial ischemia/reperfusion injury by inhibiting platelet activation via the platelet CD36 signaling pathway
Datos Bibliográficos
| ID | 14744706 |
|---|---|
| Autores | Min Wang (0000-0001-8567-8125, Chinese Academy of Medical Sciences & Peking Union Medical College), Lingxu Li (0009-0003-6952-0127, Chinese Academy of Medical Sciences & Peking Union Medical College), Shuāng Táng (0000-0002-3416-8739, Chinese Academy of Medical Sciences & Peking Union Medical College), Jianxun Liu (0000-0003-0722-152X, Xiyuan Hospital, autor de correspondencia), Shusen Liu (0009-0007-7736-2754, Chinese Academy of Medical Sciences & Peking Union Medical College), Jingxue Ye (0000-0002-0301-7305, Chinese Academy of Medical Sciences & Peking Union Medical College), Gang Ding (0000-0002-7454-2238, Chinese Academy of Medical Sciences & Peking Union Medical College, autor de correspondencia), Guibo Sun (0000-0002-9476-1243, Chinese Academy of Medical Sciences & Peking Union Medical College, autor de correspondencia) |
| Idioma | EN |
| Referencias citadas | 29 |
Blood stasis · Blood viscosity · CD36 · Clot retraction · Pathology · Platelet · Platelet activation · Receptor · Signal transduction · Thrombin · Traditional Chinese medicine · Cardiac Ischemia and Reperfusion · Chemistry · Lipid metabolism and disorders · Medicine · Traditional Chinese Medicine Analysis · Biochemistry · Internal Medicine · Pharmacology
AutoDock Vina 1.2.0
Evolution of the adaptogenic concept from traditional use to medical systems
The effects of Buyang Huanwu Decoction on hemorheological disorders and energy metabolism in rats with coronary heart disease
Qilong capsule alleviates ponatinib-induced ischemic stroke in a zebrafish model by regulating coagulation, inflammation and apoptosis
| Altamente citado | No |
|---|